The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · see citing works

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works

CpG-rich islands and the function of DNA methylation

Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · see citing works

Participation of p53 protein in the cellular response to DNA damage.

Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761 · see citing works

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works

CpG islands in vertebrate genomes.

Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,462 · see citing works

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,338 · see citing works

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,978 · see citing works

Amplification of a gene encoding a p53-associated protein in human sarcomas

Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949 · see citing works

The p53-mdm-2 autoregulatory feedback loop.

Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works

The “initiator” as a transcription control element

Smale, S. T., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90176-1 · Cited by 1,572 · see citing works

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485 · see citing works

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341 · see citing works

mdm2 expression is induced by wild type p53 activity.

Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290 · see citing works

Germline p16 mutations in familial melanoma

Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 1,252 · see citing works

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works

Database of p53 gene somatic mutations in human tumors and cell lines.

Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 860 · see citing works

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855 · see citing works

DNA Strand Breaks: the DNA Template Alterations That Trigger p53-Dependent DNA Damage Response Pathways

Nelson, W. G., & Kastan, M. B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1815 · Cited by 850 · see citing works

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752 · see citing works

Regulation of p16 <i> ^CDKN2 </i> Expression and Its Implications for Cell Immortalization and Senescence

Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733 · see citing works

Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53

Chin, K., Ueda, K., Pastan, I. H., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726 · see citing works

Distinct roles for E2F proteins in cell growth control and apoptosis

DeGregori, J. V., Leone, G. W., Miron, A., Jakoi, L., & Nevins, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7245 · Cited by 704 · see citing works

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Gonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 695 · see citing works

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works

Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses.Preprint

Jones, N., Rigby, P. W. J., & Ziff, E. B. (1988) · Genes & Development · doi:10.1101/gad.2.3.267 · Cited by 675 · see citing works

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659 · see citing works

Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.Preprint

Macleod, D., Charlton, J., Mullins, J. J., & Bird, A. P. (1994) · Genes & Development · doi:10.1101/gad.8.19.2282 · Cited by 596 · see citing works

Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.

Herman, J. G., Jen, J., Merlo, A. U., & Baylin, S. B. (1996) · PubMed · Cited by 571 · see citing works

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

Reich, N. C., & Levine, A. J. (1984) · Nature · doi:10.1038/308199a0 · Cited by 517 · see citing works

Wild-type p53 binds to the TATA-binding protein and represses transcription.

Seto, E., Usheva, A., Zambetti, G. P., Momand, J. A., Horikoshi, N., Weinmann, R. S., Levine, A. J., & Shenk, T. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504 · see citing works

Genetic determinants of p53-induced apoptosis and growth arrest.Preprint

Polyák, K., Waldman, T. A., He, T., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · doi:10.1101/gad.10.15.1945 · Cited by 458 · see citing works

Wild-type p53 can down-modulate the activity of various promoters.

Ginsberg, D., Mechta‐Grigoriou, F., Yaniv, M., & Oren, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9979 · Cited by 434 · see citing works

Sequence-specific transcriptional activation is essential for growth suppression by p53.

Pietenpol, J. A., Tokino, T., Thiagalingam, S., El‐Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406 · see citing works

Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.

Santhanam, U., Ray, A., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7605 · Cited by 390 · see citing works

Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.

Bender, C. M., Pao, M. M., & Jones, P. A. (1998) · PubMed · Cited by 386 · see citing works

Complex structure and regulation of the P16 (MTS1) locus.

Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383 · see citing works

Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

Parry, D., Bates, S., Mann, D. J., & Peters, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07026.x · Cited by 354 · see citing works

A novel p16INK4A transcript.

Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329 · see citing works

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

Mack, D. H., Vartikar, J., Pipas, J. M., & Laimins, L. A. (1993) · Nature · doi:10.1038/363281a0 · Cited by 322 · see citing works

Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation

Proudfoot, N. J. (1986) · Nature · doi:10.1038/322562a0 · Cited by 309 · see citing works

An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1

Shrivastava, A., & Calame, K. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.24.5151 · Cited by 301 · see citing works

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Mercer, W. E., Shields, M. T., Lin, D. P., Appella, E., & Ullrich, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1958 · Cited by 248 · see citing works

DNA tumor virus transforming proteins and the cell cycle

Morán, E. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80342-9 · Cited by 238 · see citing works

De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.

Jones, P. A., Wolkowicz, M. J., Rideout, W. M., Gonzales, F. A., Marziasz, C. M., Coetzee, G. A., & Tapscott, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6117 · Cited by 234 · see citing works

Transcriptional activation by p53 correlates with suppression of growth but not transformation

Crook, T. J. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233 · see citing works

Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site.

Means, A. L., & Farnham, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.653 · Cited by 223 · see citing works

E2F-6, a member of the E2F family that can behave as a transcriptional repressor

Trimarchi, J. M., Fairchild, B., Verona, R. I., Moberg, K. H., Andon, N. L., & Lees, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2850 · Cited by 223 · see citing works

Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

Tam, S. W., Shay, J. W., & Pagano, M. (1994) · PubMed · Cited by 222 · see citing works

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARF

Quelle, D. E., Cheng, M. M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 217 · see citing works

DNA Strand Breaks: the DNA Template Alterations That Trigger p53-Dependent DNA Damage Response Pathways

Nelson, W. G., & Kastan, M. B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1815-1823.1994 · Cited by 205 · see citing works

Parental imprinting of autosomal mammalian genes

Efstratiadis, A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80054-1 · Cited by 201 · see citing works

The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.

Gonzalgo, M. L., Hayashida, T., Bender, C. M., Pao, M. M., Tsai, Y., Gonzales, F. A., Nguyen, H. D., Nguyen, T. T., & Jones, P. A. (1998) · PubMed · Cited by 200 · see citing works

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Ünsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 199 · see citing works

Paleobotanical Evidence for High Altitudes in Nevada During the Miocene

Wolfe, J. A., Schorn, H. E., Forest, C. E., & Molnár, P. (1997) · Science · doi:10.1126/science.276.5319.1672 · Cited by 183 · see citing works

Inhibition of viral and cellular promoters by human wild-type p53

Subler, M. A., Martin, D. W., & Deb, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4757-4762.1992 · Cited by 171 · see citing works

The initiator directs the assembly of a transcription factor IID-dependent transcription complex.

Cárcamo, J. M., Buckbinder, L., & Reinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8052 · Cited by 169 · see citing works

Splicing into Senescence: The Curious Case of p16 and p19ARF

Haber, D. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80441-9 · Cited by 144 · see citing works

Role of transcriptional interference in the Drosophila melanogaster Adh promoter switch

Corbin, V., & Maniatis, T. (1989) · Nature · doi:10.1038/337279a0 · Cited by 142 · see citing works

Transcriptional Activation of the Epstein-Barr Virus Latency C Promoter after 5-Azacytidine Treatment: Evidence that Demethylation at a Single CpG Site Is Crucial

Robertson, K. D., Hayward, S. D., Ling, P. D., Samid, D., & Ambinder, R. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6150 · Cited by 125 · see citing works

Tumor-suppressor p53 and the cell cycle

Perry, M. E., & Levine, A. J. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80340-5 · Cited by 118 · see citing works

Negative regulation of the human epsilon-globin gene by transcriptional interference: role of an Alu repetitive element.

Wu, J., Grindlay, G. J., Bushel, P. R., Mendelsohn, L. G., & Allan, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1209 · Cited by 108 · see citing works

Characterization of the human p53 gene promoter.

Tuck, S. P., & Crawford, L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.2163 · Cited by 107 · see citing works

p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.

Liggett, W. H., Sewell, D. A., Rocco, J., Ahrendt, S. A., Koch, W. M., & Sidransky, D. (1996) · PubMed · Cited by 98 · see citing works

Transcription Initiation from the Dihydrofolate Reductase Promoter Is Positioned by HIP1 Binding at the Initiation Site

Means, A. L., & Farnham, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.653-661.1990 · Cited by 72 · see citing works

Promoter occlusion prevents transcription of adenovirus polypeptide IX mRNA until after DNA replication.Preprint

Vales, L. D., & Darnell, J. E., Jr. (1989) · Genes & Development · doi:10.1101/gad.3.1.49 · Cited by 65 · see citing works

Erratum: Genetic determinants of p53-induced apoptosis and growth arrest ((Genes and Development (1996) 10 (1945-1952))

Polyák, K., Waldman, T. A., He, T., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · Cited by 65 · see citing works

Multiple types of aberrations in the p16 (INK4a) and the p15INK4b genes in 30 esophageal squamous‐cell‐carcinoma cell lines

Tanaka, H., Shimada, Y., Imamura, M., Shibagaki, I., & Ishizaki, K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4 · Cited by 52 · see citing works

Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter

Robertson, K. D., & Ambinder, R. F. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6445-6454.1997 · Cited by 49 · see citing works

Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp)

Puglielli, M. T., Desai, N., & Speck, S. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.120-128.1997 · Cited by 42 · see citing works

Transcriptional Regulation of the Human PAX6 Gene Promoter

Xu, Z., & Saunders, G. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3430 · Cited by 39 · see citing works

p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression.

Cj, L. (1996) · PubMed · Cited by 39 · see citing works

Negative Regulation of the Human ε-Globin Gene by Transcriptional Interference: Role of an Alu Repetitive Element

Wu, J. T., Grindlay, G. J., Bushel, P. R., Mendelsohn, L. G., & Allan, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1209-1216.1990 · Cited by 36 · see citing works

Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine

Rashbaum, S. A., & Cozzarelli, N. R. (1976) · Nature · doi:10.1038/264679a0 · Cited by 32 · see citing works

Proliferation, cell cycle and apoptosis in cancer

Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,383 · see citing works

Apoptosis

Johnstone, R. W., Ruefli, A. A., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00625-6 · Cited by 2,236 · see citing works

A gene hypermethylation profile of human cancer.

Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032 · see citing works

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,235 · see citing works

E2F integrates cell cycle progression with DNA repair, replication, and G ₂ /M checkpoints

Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes &amp; Development · doi:10.1101/gad.949802 · Cited by 1,125 · see citing works

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942 · see citing works

Awakening guardian angels: drugging the p53 pathway

Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · see citing works

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

Robertson, K. D., Uzvölgyi, É., Liang, G., Talmadge, C. B., Sümegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 854 · see citing works

Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all

Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · see citing works

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

Esteller, M., & Herman, J. G. (2001) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743 · see citing works

DNA methylation, methyltransferases, and cancer

Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 732 · see citing works

Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 723 · see citing works

The DNA methylation paradox

Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665 · see citing works

The cellular response to p53: the decision between life and death

Sionov, R. V., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203130 · Cited by 600 · see citing works

ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM

Esteller, M. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549 · see citing works

UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer

de Gruijl, F. R., van Kranen, H. J., & Mullenders, L. H. F. (2001) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(01)00199-3 · Cited by 546 · see citing works

Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.

Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 530 · see citing works

twist is a potential oncogene that inhibits apoptosis

Maestro, R., Tos, A. P. D., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D. H., & Hannon, G. J. (1999) · Genes &amp; Development · doi:10.1101/gad.13.17.2207 · Cited by 516 · see citing works

Epigenetic patterns in the progression of esophageal adenocarcinoma.

Eads, C. A., Lord, R. V., Wickramasinghe, K. S., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., et al. (2001) · PubMed · Cited by 500 · see citing works

p53 and E2f: partners in life and death

Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498 · see citing works

Emerging concepts in colorectal neoplasia

Jass, J. R., Whitehall, V., Young, J. P., & Leggett, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.35392 · Cited by 489 · see citing works

Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

Esteller, M., Tórtola, S., Toyota, M., Capellá, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 464 · see citing works

Methylation matters

Costello, J., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 447 · see citing works

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway

Bulavin, D. V., Dudgeon, C., Nannenga, B., Timofeev, O. N., Donehower, L. A., Anderson, C. W., Appella, E., & Fornace, A. J. (2004) · Nature Genetics · doi:10.1038/ng1317 · Cited by 410 · see citing works

Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14 ARF Tumor Suppressor

Dimri, G. P., Itahana, K., Acosta, M., & Campisi, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.273-285.2000 · Cited by 393 · see citing works

Mechanisms and Regulation of Cellular Senescence

Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395 · see citing works

The epigenetics of aging and neurodegeneration

Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381 · see citing works

Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration

Zhu, D., & Bourguignon, L. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2 · Cited by 72 · see citing works

Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.

Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J., Liang, G., & Jones, P. A. (2002) · PubMed · Cited by 383 · see citing works

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression

Cunnington, M. S., Santibanez‐Koref, M., Mayosi, B. M., Burn, J., & Keavney, B. D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000899 · Cited by 379 · see citing works

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers

Jacobs, J. J. L., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van de Vijver, M. J., Koh, E. Y., Daley, G. Q., et al. (2000) · Nature Genetics · doi:10.1038/81583 · Cited by 368 · see citing works

Epigenetic changes in colorectal cancer

Kondo, Y., & Issa, J. J. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1025806911782 · Cited by 335 · see citing works

Untitled work

(1999) · PubMed · Cited by 338 · see citing works

Relevance of DNA methylation in the management of cancer

Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329 · see citing works

p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

Kim, D. H., Nelson, H. H., Wiencke, J. K., Zheng, S., Christiani, D. C., Wain, J. C., Mark, E. J., & Kelsey, K. T. (2001) · PubMed · Cited by 326 · see citing works

CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase

Vigo, E., Müller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M. C., & Helin, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6379 · Cited by 326 · see citing works

Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis

Hershko, T., & Ginsberg, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312866200 · Cited by 322 · see citing works

The genetics of the E2F family of transcription factors: shared functions and unique roles

DeGregori, J. V. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295 · see citing works

p53 Family and Cellular Stress Responses in Cancer

Pflaum, J., Schlosser, S., & ller, M. M. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 294 · see citing works

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

Ichimura, K., Bondesson, M., Goike, H., Schmidt, E., Moshref, A., & Collins, V. P. (2000) · PubMed · Cited by 282 · see citing works

A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family

Randerson‐Moor, J. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.55 · Cited by 280 · see citing works

Myc Requires Distinct E2F Activities to Induce S Phase and Apoptosis

Leone, G. W., Sears, R. C., Huang, E. S., Rempel, R. E., Nuckolls, F., Park, C., Giangrande, P. H., Wu, L., Saavedra, H. I., Field, S. J., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00275-1 · Cited by 265 · see citing works

The E2F transcription factors: key regulators of cell proliferation

Müller, H., & Helin, K. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00030-x · Cited by 259 · see citing works

The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia

Linggi, B. E., Müller‐Tidow, C., van de Locht, L. T., Hu, M., Nip, J., Serve, H. L., Berdel, W. E., van der Reijden, B., Quelle, D. E., Rowley, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm726 · Cited by 256 · see citing works

Epigenetic mechanisms in Alzheimer's disease

Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C. M., Coleman, P. D., & Rogers, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.017 · Cited by 258 · see citing works

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo

Ringshausen, I., O'Shea, C. C., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.010 · Cited by 256 · see citing works

Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim

Zhao, Y., Tan, J. Y., Zhuang, L., Jiang, X., Liu, E. T., & Yu, Q. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505585102 · Cited by 246 · see citing works

Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation

Nguyen, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.22.4598 · Cited by 246 · see citing works

Cancer epigenetics

Momparler, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206774 · Cited by 242 · see citing works

p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas

Nakamura, M., Watanabe, T., Klangby, U., Asker, C., Wiman, K. G., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00388.x · Cited by 237 · see citing works

CpG methylation as a mechanism for the regulation of E2F activity

Campanero, M. R., Armstrong, M. I., & Flemington, E. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100340697 · Cited by 230 · see citing works

Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers

Kondo, Y. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.4.455 · Cited by 223 · see citing works

Dial 9-1-1 for p53: Mechanisms of p53 Activation by Cellular Stress

Ljungman, M. E. (2000) · Neoplasia · doi:10.1038/sj.neo.7900073 · Cited by 218 · see citing works

Hypermethylation of tumor suppressor genes in cancer

Herman, J. G. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0138 · Cited by 221 · see citing works

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

Nilsson, J. A., Keller, U. B., Baudino, T. A., Yang, C., Norton, S., Old, J. B., Nilsson, L. M., Neale, G. A. M., Kramer, D. L., Porter, C. W., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.036 · Cited by 210 · see citing works

Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation

Damalas, A., Kahan, S., Shtutman, M. S., Ben‐Ze'ev, A., & Oren, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 206 · see citing works

Epigenetic biomarkers for human cancer: The time is now

Mulero‐Navarro, S., & Esteller, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.03.001 · Cited by 205 · see citing works

Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia

Magdinier, F., & Wolffe, A. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101617298 · Cited by 197 · see citing works

E2F1 pathways to apoptosis

Ginsberg, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03270-2 · Cited by 186 · see citing works

Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.

Xing, E. P., Nie, Y., Song, Y., Yang, G., Cai, Y., Wang, L., & Yang, C. S. (1999) · PubMed · Cited by 180 · see citing works

Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer

Wallner, M., Herbst, A., Behrens, A., Crispin, A., Stieber, P., Göke, B., Lamerz, R., & Kolligs, F. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1264 · Cited by 183 · see citing works

Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis

Eischen, C. M., Roussel, M. F., Korsmeyer, S. J., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7653-7662.2001 · Cited by 183 · see citing works

Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer

Hirt‐Burri, N., Shaw, P. H., Bouzourène, H., Sordat, I., Sordat, B., Gillet, M., Schorderet, D. F., Bosman, F. T., & Chaubert, P. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780230 · Cited by 181 · see citing works

Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas

Baur, A. S., Shaw, P., Hirt‐Burri, N., Delacrétaz, F., Bosman, F. T., & Chaubert, P. (1999) · Blood · doi:10.1182/blood.v94.5.1773 · Cited by 168 · see citing works

Involvement of E2F transcription factor family in cancer

Tsantoulis, P. K., & Gorgoulis, V. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.005 · Cited by 162 · see citing works

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma

Carr‐Wilkinson, J., O’Toole, K., Wood, K. M., Challen, C., Baker, A., Julian Board, Evans, L. E., Cole, M. F., Cheung, N. V., Boos, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1865 · Cited by 162 · see citing works

Sequential 5-Aza-2’-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1

Weiser, T. S., Guo, Z. S., Ohnmacht, G. A., Parkhurst, M. L., Tong-On, P., Marincola, F. M., Fischette, M. R., Yu, X., Chen, G. A., Hong, J. A., et al. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00010 · Cited by 162 · see citing works

Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors

Piepkorn, M. W. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104687 · Cited by 160 · see citing works

The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 via a Variant T-site in the Initiator

Lingbeek, M. E., Jacobs, J. J. L., & van Lohuizen, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200403200 · Cited by 160 · see citing works

BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets

MacLachlan, T. K., Takimoto, R., & El‐Deiry, W. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4280-4292.2002 · Cited by 160 · see citing works

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.

Lind, G. E., Thorstensen, L., Løvig, T., Meling, G. I., Hamelin, R., Rognum, T. O., Esteller, M., & Lothe, R. A. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-28 · Cited by 157 · see citing works

Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element

Johnson, R. A., Ince, T. A., & Scotto, K. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100121200 · Cited by 158 · see citing works

Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells

Tao, Q. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2091 · Cited by 155 · see citing works

Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b

Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 154 · see citing works

Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation

Qazi, T. J., Quan, Z., Mir, A., & Qing, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0357-6 · Cited by 153 · see citing works

Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer

Wynter, C. V. A. (2004) · Gut · doi:10.1136/gut.2003.030841 · Cited by 151 · see citing works

Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications

Sigalotti, L., Fratta, E., Coral, S., Cortini, E., Covre, A., Nicolay, H. J. M., Anzalone, L., Pezzani, L., Giacomo, A. M. D., Fonsatti, E., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21066 · Cited by 142 · see citing works

Apoptosis in cancer—implications for therapy

Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 144 · see citing works

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

Wolff, E. M., Liang, G., & Jones, P. A. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0318 · Cited by 137 · see citing works

Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy

Wang, J., Yu, J., Tan, M., Jiang, T., & Tan, L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.003 · Cited by 135 · see citing works

A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal Transition

Kumar, S., Park, S. H., Cieply, B. W., Schupp, J. E., Killiam, E. J., Zhang, F., Rimm, D. L., & Frisch, S. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01342-10 · Cited by 132 · see citing works

DNA methylation and apoptosis

Gopisetty, G., RAMACHANDRAN, K., & Singal, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.010 · Cited by 131 · see citing works

Methylation and colorectal cancer

Jubb, A. M., Bell, S. M., & Quirke, P. (2001) · The Journal of Pathology · doi:10.1002/path.923 · Cited by 131 · see citing works

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

Esteller, M., Cordon‐Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capellá, G., Peinado, M. A., Matías‐Guiu, X., Prat, J., et al. (2001) · PubMed · Cited by 132 · see citing works

Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.

Kim, D.-H., Kim, J. S., Ji, Y., Shim, Y. M., Kim, H., Han, J., & Park, J. (2003) · PubMed · Cited by 131 · see citing works

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

Sánchez‐Céspedes, M., Reed, A. L., Buta, M. R., Li, W., Westra, W. H., Herman, J. G., Yang, S. C., Jen, J., & Sidransky, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203003 · Cited by 130 · see citing works

The impact of chromatin in human cancer: linking DNA methylation to gene silencing

Ballestar, E. (2002) · Carcinogenesis · doi:10.1093/carcin/23.7.1103 · Cited by 129 · see citing works

Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells

Yang, C., You, L., Yeh, C., Chang, J. W. C., Zhang, F., McCormick, F. P., & Jablons, D. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.636 · Cited by 126 · see citing works

Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a

Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 124 · see citing works

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker

Teodoridis, J. M., Strathdee, G. R., & Brown, R. E. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.06.005 · Cited by 123 · see citing works

Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2

Rogoff, H. A., Pickering, M., Frame, F. M., Debatis, M. E., Sánchez, Y., Jones, S. N., & Kowalik, T. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2968-2977.2004 · Cited by 123 · see citing works

Increased Frequency of Aberrations in the p53/MDM2/p14ARF Pathway in Neuroblastoma Cell Lines Established at Relapse

Carr, J., Bell, E., Pearson, A. D. J., Kees, U. R., Beris, H., Lunec, J., & Tweddle, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2623 · Cited by 119 · see citing works

Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis.

Pogribny, I. P., Pogribna, M., Christman, J. K., & James, S. J. (2000) · PubMed · Cited by 119 · see citing works

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas

Alonso, M. E., Bello, M. J., González‐Gómez, P., Arjona, D., Lomas, J., de Campos, J. M., Isla, A., Sarasa, J. L., & REY, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00928-7 · Cited by 115 · see citing works

Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

Robertson, K. D., & Jones, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202737 · Cited by 113 · see citing works

The retinoblastoma gene product interacts with maintenance human DNA (cytosine‐5) methyltransferase and modulates its activity

Pradhan, S., & Kim, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.779 · Cited by 112 · see citing works

E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis

Rogoff, H. A., Pickering, M., Debatis, M. E., Jones, S. N., & Kowalik, T. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5308-5318.2002 · Cited by 111 · see citing works

A Novel Repressive E2F6 Complex Containing the Polycomb Group Protein, EPC1, That Interacts with EZH2 in a Proliferation-specific Manner

Attwooll, C. L., Oddi, S., Cartwright, P., Prosperini, E., Agger, K., Steensgaard, P., Wagener, C., Sardet, C., Moroni, M. C., & Helin, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412509200 · Cited by 111 · see citing works

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma

Morris, M. R., Hesson, L. B., Wagner, K. J., Morgan, N. V., Astuti, D., Lees, R. D., Cooper, W. N., Lee, J., Gentle, D., MacDonald, F., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206914 · Cited by 108 · see citing works

Biallelic Mutations in p16^INK4a Confer Resistance to Ras- and Ets-Induced Senescence in Human Diploid Fibroblasts

Huot, T. J., Rowe, J., Harland, M., Drayton, S., Brookes, S., Gooptu, C., Purkis, P., Fried, M., Bataille, V., Hara, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8135-8143.2002 · Cited by 107 · see citing works

Regulation of the p14ARF promoter by DNA methylation

Badal, V., Ménendez, S., Coomber, D., & Lane, D. P. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5137 · Cited by 32 · see citing works

Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas

Meléndez, B., Malumbres, M., de Castro, I. P., Santos, J., Pellicer, À., & Fernández‐Piqueras, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.817 · Cited by 21 · see citing works

Abstract SY29-03: Regulation of cellular self-renewal by the ARF

Sherr, C. J., Gromley, A., Churchman, M. L., & Volanakis, E. J. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-sy29-03

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works

[Interactive pathway of ARF-mdm2-p53].

Lin, J., & Zhu, M. (2003) · PubMed · Cited by 6 · see citing works